Drugs for lipid disorders, antiplatelet drugs and fibrinolytics

Drugs used to treat hyperlipidaemias, to reduce platelet aggregation and to achieve thrombolysis are discussed here. Their major mechanisms of action, key pharmacokinetic principles essential for their safe use and important adverse effects are explained. Each class of drug is also given context for effective clinical use.